Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Nantes University Hospital: Clinical Trials & FDA Approval Profile

Nantes University Hospital (Global / Institutional) sponsors 55 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 31 active protocols (22 recruiting now), 10 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)10.9%
Median Closed Enrollment vs National (145 pts)73 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Nantes University Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)55
Active Pipeline (Recruiting Now)31 (22)
Completed vs Stopped Early10 / 6 (10.9%)
Median Closed Actual Enrollment73 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Nantes University Hospital
Hospital Research SiteLocationShared Protocols
CHU de NantesNantes23
CHU NantesNantes13
CHU AngersAngers11

Explore interactive annual charts and M&A subsidiary rollups in the Nantes University Hospital Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI